FLNA Price / Book | Filana Therapeutics, Inc.

FILANA THERAPEUTICS, INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

FILANA THERAPEUTICS, INC. price/book ratio for the quarter ending 2026-03-31 was 1.2, a 111.00% increase year-over-year.
FILANA THERAPEUTICS, INC. price/book ratio for the quarter ending 2025-12-31 was 1.29, a 64.66% increase year-over-year.
FILANA THERAPEUTICS, INC. price/book ratio for the quarter ending 2025-09-30 was 1.72, a 79.66% decline year-over-year.
FILANA THERAPEUTICS, INC. price/book ratio for the quarter ending 2025-06-30 was 0.99, a 68.30% decline year-over-year.
FILANA THERAPEUTICS, INC. price/book ratio for fiscal 2026 was 1.2.
FILANA THERAPEUTICS, INC. price/book ratio for fiscal 2025 was 1.29, a 64.66% increase from fiscal 2024.
FILANA THERAPEUTICS, INC. price/book ratio for fiscal 2024 was 0.78, a 88.71% decline from fiscal 2023.
FILANA THERAPEUTICS, INC. price/book ratio for fiscal 2023 was 6.92, a 27.65% increase from fiscal 2022.

Available history: 2010-12-31 to 2026-03-31
Data captured: 2026-03-31

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-03-31	1.2	$81.64M	$68.14M
2025-12-31	1.29	$95.65M	$74.4M
2025-09-30	1.72	$140.58M	$81.57M
2025-06-30	0.99	$87.44M	$87.97M
2025-03-31	0.57	$72.46M	$127.62M
2024-12-31	0.78	$113.76M	$145.7M
2024-09-30	8.47	$1.41B	$166.64M
2024-06-30	3.14	$592.51M	$188.97M
2024-03-31	11.16	$877.51M	$78.6M
2023-12-31	6.92	$950.75M	$137.47M
2023-09-30	4.52	$701.04M	$155.12M
2023-06-30	5.73	$1.03B	$179.35M
2023-03-31	4.94	$1.01B	$204.01M
2022-12-31	5.42	$1.23B	$227.54M
2022-09-30	8.43	$1.68B	$198.72M
2022-06-30	5.16	$1.13B	$218.37M
2022-03-31	6.27	$1.49B	$237.09M
2021-12-31	6.89	$1.75B	$253.92M
2021-09-30	9.28	$2.48B	$267.57M
2021-06-30	12.36	$3.42B	$276.48M
2021-03-31	6.4	$1.8B	$281.19M
2020-12-31	2.61	$240.32M	$92.2M
2020-09-30	12.28	$294.41M	$23.97M
2020-06-30	3.17	$76.75M	$24.18M
2020-03-31	4.09	$101.64M	$24.83M
2019-12-31	5.14	$113.58M	$22.1M
2019-09-30	1.18	$20.66M	$17.45M
2019-06-30	1.17	$20.84M	$17.82M
2019-03-31	1.2	$22.21M	$18.55M
2018-12-31	0.75	$14.64M	$19.63M
2018-09-30	0.87	$17.39M	$19.97M
2018-06-30	1.66	$14.2M	$8.55M
2018-03-31	4.75	$48.89M	$10.3M
2017-12-31	2.72	$26.38M	$9.7M
2017-09-30	2.36	$26.84M	$11.37M
2017-06-30	2.06	$27.37M	$13.27M
2017-03-31	17.19	$287.46M	$16.72M
2016-12-31	1.41	$26.3M	$18.64M
2016-09-30	15.9	$322.99M	$20.32M
2016-06-30	30.77	$707.36M	$22.99M
2016-03-31	28.25	$714.25M	$25.28M
2015-12-31	19.09	$560.51M	$29.37M
2015-09-30	17.73	$586.14M	$33.07M
2015-06-30	15.42	$554.11M	$35.94M
2015-03-31	15.75	$605.35M	$38.44M
2014-12-31	16.23	$650.19M	$40.06M
2014-09-30	30.39	$1.25B	$41.21M
2014-06-30	42.05	$1.84B	$43.65M
2014-03-31	38.34	$1.75B	$45.7M
2013-12-31	32.05	$1.55B	$48.3M
2013-09-30	60.7	$865.14M	$14.25M
2013-06-30	49.47	$701.29M	$14.18M
2013-03-31	81.17	$1.09B	$13.41M
2012-12-31	65.46	$859.85M	$13.14M
2012-09-30	34.17	$1.58B	$46.33M
2012-06-30	31.81	$1.47B	$46.17M
2012-03-31	25.02	$1.13B	$45.3M
2011-12-31	26.8	$1.19B	$44.39M
2011-09-30	34.2	$1.49B	$43.49M
2010-12-31	61.56	$2.03B	$32.93M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-03-31	1.2	$81.64M	$68.14M
2025-12-31	1.29	$95.65M	$74.4M
2024-12-31	0.78	$113.76M	$145.7M
2023-12-31	6.92	$950.75M	$137.47M
2022-12-31	5.42	$1.23B	$227.54M
2021-12-31	6.89	$1.75B	$253.92M
2020-12-31	2.61	$240.32M	$92.2M
2019-12-31	5.14	$113.58M	$22.1M
2018-12-31	0.75	$14.64M	$19.63M
2017-12-31	2.72	$26.38M	$9.7M
2016-12-31	1.41	$26.3M	$18.64M
2015-12-31	19.09	$560.51M	$29.37M
2014-12-31	16.23	$650.19M	$40.06M
2013-12-31	32.05	$1.55B	$48.3M
2012-12-31	65.46	$859.85M	$13.14M
2011-12-31	26.8	$1.19B	$44.39M
2010-12-31	61.56	$2.03B	$32.93M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Actinium Pharmaceuticals, Inc. (ATNM)	United States	$0.038B	2.73
PMGC Holdings Inc. (ELAB)	United States	$0.037B
Celularity Inc (CELU)	United States	$0.038B	-0.34
BriaCell Therapeutics Corp. (BCTX)		$0.037B
CervoMed Inc. (CRVO)	United States	$0.038B	-1.39
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B
Seres Therapeutics, Inc. (MCRB)	United States	$0.036B	-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32